Cite

HARVARD Citation

    Soliman, R. et al. (2022). Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukemia in children and young adults. Expert review of hematology. 15 (4), pp. 345-357. [Online]. 
  
Back to record